⌘K

Login Start Free

Home/Filings/4/0001493152-24-023516

4//SEC Filing

Bligh James 4

Accession 0001493152-24-023516

CIK 0001896212other

View on SEC.gov Company Profile

Filed

Jun 10, 8:00 PM ET

Accepted

Jun 11, 5:53 PM ET

Size

4.8 KB

Accession

0001493152-24-023516

Insider Transaction Report

Form 4

Period: 2024-06-11

CONDUIT PHARMACEUTICALS INC.CDT

DirectorCFO

Transactions

Award
Common Stock
2024-06-11+37,272→ 37,272 total

Footnotes (1)

[F1]The shares have a value in excess of the par value of the company's shares and are fully vested (fully paid and nonassessable) as of June 11, 2024.

Documents

1 file

4
ownership.xmlPrimary

Issuer

CONDUIT PHARMACEUTICALS INC.

CIK 0001896212

Entity typeother

Related Parties

1

filerCIK 0001990748

Filing Metadata

Form type: 4
Filed: Jun 10, 8:00 PM ET
Accepted: Jun 11, 5:53 PM ET
Size: 4.8 KB

View on SEC.gov